[(1S,2R,3S,4S,6R,7R,8R,14R)-4-ethenyl-3-hydroxy-2,4,7,14-tetramethyl-9-oxo-6-tricyclo[5.4.3.01,8]tetradecanyl] 2-[1-(3,4-dioxo-2-thiomorpholin-4-ylcyclobuten-1-yl)piperidin-3-yl]sulfanylacetate

C35H50N2O6S2 — CID 72944500

IUPAC[(1S,2R,3S,4S,6R,7R,8R,14R)-4-ethenyl-3-hydroxy-2,4,7,14-tetramethyl-9-oxo-6-tricyclo[5.4.3.01,8]tetradecanyl] 2-[1-(3,4-dioxo-2-thiomorpholin-4-ylcyclobuten-1-yl)piperidin-3-yl]sulfanylacetate
SMILESC=C[C@]1(C)C[C@@H](OC(=O)CSC2CCCN(c3c(N4CCSCC4)c(=O)c3=O)C2)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O
InChIInChI=1S/C35H50N2O6S2/c1-6-33(4)18-25(34(5)21(2)9-11-35(22(3)32(33)42)12-10-24(38)31(34)35)43-26(39)20-45-23-8-7-13-37(19-23)28-27(29(40)30(28)41)36-14-16-44-17-15-36/h6,21-23,25,31-32,42H,1,7-20H2,2-5H3/t21-,22+,23?,25-,31+,32+,33-,34+,35+/m1/s1
InChIKeyTUIDUSZWODQUMZ-WKBXBSPFSA-N
MW658.93 g/mol
LogP4.44
Rot. Bonds7

About [(1S,2R,3S,4S,6R,7R,8R,14R)-4-ethenyl-3-hydroxy-2,4,7,14-tetramethyl-9-oxo-6-tricyclo[5.4.3.01,8]tetradecanyl] 2-[1-(3,4-dioxo-2-thiomorpholin-4-ylcyclobuten-1-yl)piperidin-3-yl]sulfanylacetate

[(1S,2R,3S,4S,6R,7R,8R,14R)-4-ethenyl-3-hydroxy-2,4,7,14-tetramethyl-9-oxo-6-tricyclo[5.4.3.01,8]tetradecanyl] 2-[1-(3,4-dioxo-2-thiomorpholin-4-ylcyclobuten-1-yl)piperidin-3-yl]sulfanylacetate (PubChem CID 72944500) has the molecular formula C35H50N2O6S2 and a molecular weight of 658.93 g/mol. Its IUPAC name is [(1S,2R,3S,4S,6R,7R,8R,14R)-4-ethenyl-3-hydroxy-2,4,7,14-tetramethyl-9-oxo-6-tricyclo[5.4.3.01,8]tetradecanyl] 2-[1-(3,4-dioxo-2-thiomorpholin-4-ylcyclobuten-1-yl)piperidin-3-yl]sulfanylacetate.

Molecular Properties

Compound Name[(1S,2R,3S,4S,6R,7R,8R,14R)-4-ethenyl-3-hydroxy-2,4,7,14-tetramethyl-9-oxo-6-tricyclo[5.4.3.01,8]tetradecanyl] 2-[1-(3,4-dioxo-2-thiomorpholin-4-ylcyclobuten-1-yl)piperidin-3-yl]sulfanylacetate
PubChem CID72944500
Molecular FormulaC35H50N2O6S2
Molecular Weight658.93 g/mol
Exact Mass658.31
IUPAC Name[(1S,2R,3S,4S,6R,7R,8R,14R)-4-ethenyl-3-hydroxy-2,4,7,14-tetramethyl-9-oxo-6-tricyclo[5.4.3.01,8]tetradecanyl] 2-[1-(3,4-dioxo-2-thiomorpholin-4-ylcyclobuten-1-yl)piperidin-3-yl]sulfanylacetate
SMILESC=C[C@]1(C)C[C@@H](OC(=O)CSC2CCCN(c3c(N4CCSCC4)c(=O)c3=O)C2)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O
InChIInChI=1S/C35H50N2O6S2/c1-6-33(4)18-25(34(5)21(2)9-11-35(22(3)32(33)42)12-10-24(38)31(34)35)43-26(39)20-45-23-8-7-13-37(19-23)28-27(29(40)30(28)41)36-14-16-44-17-15-36/h6,21-23,25,31-32,42H,1,7-20H2,2-5H3/t21-,22+,23?,25-,31+,32+,33-,34+,35+/m1/s1
InChIKeyTUIDUSZWODQUMZ-WKBXBSPFSA-N
XLogP4.44
TPSA104.22 Ų
H-Bond Donors1
H-Bond Acceptors10
Rotatable Bonds7
Heavy Atoms45
Complexity—

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500658.93
LogP ≤ 54.44
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 1010

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'diketo_group', 'substructure': 'N/A'}, {'alert_name': 'isolated_alkene', 'substructure': 'N/A'}

Analyze [(1S,2R,3S,4S,6R,7R,8R,14R)-4-ethenyl-3-hydroxy-2,4,7,14-tetramethyl-9-oxo-6-tricyclo[5.4.3.01,8]tetradecanyl] 2-[1-(3,4-dioxo-2-thiomorpholin-4-ylcyclobuten-1-yl)piperidin-3-yl]sulfanylacetate with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of [(1S,2R,3S,4S,6R,7R,8R,14R)-4-ethenyl-3-hydroxy-2,4,7,14-tetramethyl-9-oxo-6-tricyclo[5.4.3.01,8]tetradecanyl] 2-[1-(3,4-dioxo-2-thiomorpholin-4-ylcyclobuten-1-yl)piperidin-3-yl]sulfanylacetate?
The IUPAC name of [(1S,2R,3S,4S,6R,7R,8R,14R)-4-ethenyl-3-hydroxy-2,4,7,14-tetramethyl-9-oxo-6-tricyclo[5.4.3.01,8]tetradecanyl] 2-[1-(3,4-dioxo-2-thiomorpholin-4-ylcyclobuten-1-yl)piperidin-3-yl]sulfanylacetate (CID 72944500) is [(1S,2R,3S,4S,6R,7R,8R,14R)-4-ethenyl-3-hydroxy-2,4,7,14-tetramethyl-9-oxo-6-tricyclo[5.4.3.01,8]tetradecanyl] 2-[1-(3,4-dioxo-2-thiomorpholin-4-ylcyclobuten-1-yl)piperidin-3-yl]sulfanylacetate.
What is the SMILES notation for [(1S,2R,3S,4S,6R,7R,8R,14R)-4-ethenyl-3-hydroxy-2,4,7,14-tetramethyl-9-oxo-6-tricyclo[5.4.3.01,8]tetradecanyl] 2-[1-(3,4-dioxo-2-thiomorpholin-4-ylcyclobuten-1-yl)piperidin-3-yl]sulfanylacetate?
The canonical SMILES for [(1S,2R,3S,4S,6R,7R,8R,14R)-4-ethenyl-3-hydroxy-2,4,7,14-tetramethyl-9-oxo-6-tricyclo[5.4.3.01,8]tetradecanyl] 2-[1-(3,4-dioxo-2-thiomorpholin-4-ylcyclobuten-1-yl)piperidin-3-yl]sulfanylacetate is C=C[C@]1(C)C[C@@H](OC(=O)CSC2CCCN(c3c(N4CCSCC4)c(=O)c3=O)C2)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O.
What is the InChIKey of [(1S,2R,3S,4S,6R,7R,8R,14R)-4-ethenyl-3-hydroxy-2,4,7,14-tetramethyl-9-oxo-6-tricyclo[5.4.3.01,8]tetradecanyl] 2-[1-(3,4-dioxo-2-thiomorpholin-4-ylcyclobuten-1-yl)piperidin-3-yl]sulfanylacetate?
The InChIKey is TUIDUSZWODQUMZ-WKBXBSPFSA-N. The full InChI is InChI=1S/C35H50N2O6S2/c1-6-33(4)18-25(34(5)21(2)9-11-35(22(3)32(33)42)12-10-24(38)31(34)35)43-26(39)20-45-23-8-7-13-37(19-23)28-27(29(40)30(28)41)36-14-16-44-17-15-36/h6,21-23,25,31-32,42H,1,7-20H2,2-5H3/t21-,22+,23?,25-,31+,32+,33-,34+,35+/m1/s1.
What are the key properties of [(1S,2R,3S,4S,6R,7R,8R,14R)-4-ethenyl-3-hydroxy-2,4,7,14-tetramethyl-9-oxo-6-tricyclo[5.4.3.01,8]tetradecanyl] 2-[1-(3,4-dioxo-2-thiomorpholin-4-ylcyclobuten-1-yl)piperidin-3-yl]sulfanylacetate?
[(1S,2R,3S,4S,6R,7R,8R,14R)-4-ethenyl-3-hydroxy-2,4,7,14-tetramethyl-9-oxo-6-tricyclo[5.4.3.01,8]tetradecanyl] 2-[1-(3,4-dioxo-2-thiomorpholin-4-ylcyclobuten-1-yl)piperidin-3-yl]sulfanylacetate has a molecular weight of 658.93 g/mol, XLogP of 4.44, 7 rotatable bonds, 1 hydrogen bond donors, and 10 hydrogen bond acceptors.
Where does this data come from?
All data for [(1S,2R,3S,4S,6R,7R,8R,14R)-4-ethenyl-3-hydroxy-2,4,7,14-tetramethyl-9-oxo-6-tricyclo[5.4.3.01,8]tetradecanyl] 2-[1-(3,4-dioxo-2-thiomorpholin-4-ylcyclobuten-1-yl)piperidin-3-yl]sulfanylacetate is sourced from PubChem (CID 72944500), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).